Oak Ridge Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Oak Ridge Investments’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$952K	Buy	25,649 +784	+3%	+$23.8K	0.05%	127
2026 Q1	$841K	Buy	24,865 +4,861	+24%	+$138K	0.06%	131
2025 Q4	$545K	Sell	20,004 -5,381	-21%	-$189K	0.03%	146
2025 Q3	$1.02M	Sell	25,385 -11,867	-32%	-$446K	0.07%	120
2025 Q2	$1.24M	Sell	37,252 -1,835	-5%	-$55.6K	0.09%	109
2025 Q1	$1.15M	Buy	39,087 +218	+0.6%	+$7.23K	0.1%	109
2024 Q4	$1.28M	Sell	38,869 -1,509	-4%	-$70.9K	0.1%	107
2024 Q3	$1.79M	Buy	40,378 +5,142	+15%	+$234K	0.16%	93
2024 Q2	$1.52M	Sell	35,236 -4,807	-12%	-$173K	0.14%	100
2024 Q1	$1.17M	Buy	+40,043	New	+$1.07M	0.12%	115

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Oak Ridge Investments's AGIO Position: Q2 2026 in Review

Oak Ridge Investments increased its Agios Pharmaceuticals (AGIO) stake by 3.2% in Q2 2026, buying an estimated $23.8K and bringing the position to 25,649 shares worth $952K. The position accounts for 0.05% of the portfolio, ranked #127.

Oak Ridge Investments first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.79M in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

Oak Ridge Investments held 25,649 shares of Agios Pharmaceuticals worth $952K as of Q2 2026.
Oak Ridge Investments bought 784 Agios Pharmaceuticals shares in Q2 2026, an estimated $23.8K.
Agios Pharmaceuticals made up 0.05% of Oak Ridge Investments's portfolio in Q2 2026, its #127 holding.
Oak Ridge Investments first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Oak Ridge Investments's Agios Pharmaceuticals position peaked at $1.79M in Q3 2024.
238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.